Evidence map›Paper›PMID 40965666›Full record

ArticleAnnals of hematology2025

Survival analysis and prognosis model construction of elderly patients with acute promyelocyticleukemia: a retrospective study based on SEER database.

Jinhong Jiang, Yonghua Liu, Yuxiao Zeng, Yifen Lan, Bingmu Fang

Abstract read
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinhong JiangDepartment of Hematology, The Sixth Hospital Affiliated to Wenzhou Medical University, Wenzhou, 323000, China. jjhongjiang@163.com.
Yonghua LiuDepartment of Hematology, The Sixth Hospital Affiliated to Wenzhou Medical University, Wenzhou, 323000, China.
Yuxiao ZengDepartment of Hematology, The Sixth Hospital Affiliated to Wenzhou Medical University, Wenzhou, 323000, China.
Yifen LanDepartment of Hematology, The Sixth Hospital Affiliated to Wenzhou Medical University, Wenzhou, 323000, China.
Bingmu FangDepartment of Hematology, The Sixth Hospital Affiliated to Wenzhou Medical University, Wenzhou, 323000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The survival and death cause in elderly acute promyelocytic leukemia (APL) patients were analyzed and a prognosis model was constructed. Retrospectively, the medical data of elderly APL patients (N = 1723, from year 2000 to 2020) were gained from surveillance, epidemiology, and end results (SEER) database, and patients were randomly divided into train set and test set 1 (7:3). Test set 2 was composed of 17 APL patients from our hospital. Single factor and multi-factor analyses were performed by COX regression analysis. Death causes were analyzed among dead APL patients. Prognosis prediction model was constructed and verified. Single factor analysis results showed that age, marital status, income, year of diagnosis, months from diagnosis to treatment and chemotherapy were highly correlated with the death of APL patients. Multi-factor analysis results indicated that age, year of diagnosis and chemotherapy could independently serve as predictors to the death of APL patients. More patient succumbed to APL relative to other causes. The prognosis model had a higher diagnostic value for 0.5-year (AUC = 0.797) overall survival in train set, and for 2-year (AUC = 0.784) overall survival in test set 1. 1-year survival prediction in train set and test set 1 indicated the stability of the model. Age, year of diagnosis and chemotherapy are the independent risk factors, and APL is the leading cause of death in elderly APL patients. The prognosis model has a good clinical prediction value for elderly APL patients.

Indexed as

Leukemia, Promyelocytic, AcuteSEER ProgramAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesSurvival AnalysisSurvival RateAcute promyelocytic leukemiaPrediction modelPrognosisSEER databaseSurvival analysis

Identifiers

PMID40965666
PMCPMC12552279

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.